A041

Polaris AI Pharma Corp. Stock Price

KOSDAQ:A041910 Community·₩91.4b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

A041910 Share Price Performance

₩6,880.00
-40.00 (-0.58%)
₩6,880.00
-40.00 (-0.58%)
Price ₩6,880.00

A041910 Community Narratives

There are no narratives available yet.

Recent A041910 News & Updates

Polaris AI Pharma Corp. Key Details

₩63.9b

Revenue

₩51.1b

Cost of Revenue

₩12.9b

Gross Profit

₩11.9b

Other Expenses

₩989.5m

Earnings

Last Reported Earnings
Sep 30, 2022
Next Reporting Earnings
n/a
Earnings per share (EPS)
0
Gross Margin
0%
Net Profit Margin
0%
Debt/Equity Ratio
0%

Polaris AI Pharma Corp. Competitors

 
 
 
 
 
 
 
 
 
 
 
 

Snowflake Analysis

Low risk not a dividend payer.

3 Risks
0 Rewards

About A041910

Founded
1996
Employees
n/a
CEO
Jae-Chul Kim
WebsiteView website
www.polarisaipharma.com

Polaris AI Pharma Corp. engages in the manufacture and sale of pharmaceuticals products in South Korea and internationally. It also offers its products for various therapeutic categories, such as diagnostic acid, antidiabetic, anti-depressants, and cholinergic. The company was formerly known as EstechPharma Co., Ltd. and changed its name to Polaris AI Pharma Corp. in March 2024. The company was founded in 1996 and is headquartered in Hwaseong-si, South Korea.

Market Insight

Rare earths may be a sliver of the global metals market, but they punch far above their weight. These obscure elements are the invisible wiring of modern life.
Continue reading

South Korean Market Performance

  • 7 Days: 3.4%
  • 3 Months: 13.2%
  • 1 Year: 33.0%
  • Year to Date: 44.6%
Over the last 7 days, the market has risen 3.4%, driven by gains of 7.2% in the Information Technology sector. As for the past 12 months, the market is up 33%. Earnings are forecast to grow by 24% annually. Market details ›